Vanguard Group Inc Magenta Therapeutics, Inc. Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.41 - $0.86 $1,715 - $3,597	4,183 Added 0.21%	1,968,421 $1.56 Million
Q4 2022 Feb 10, 2023	BUY	$0.36 - $1.59 $290 - $1,281	806 Added 0.04%	1,964,238 $785,000
Q3 2022 Nov 14, 2022	BUY	$1.26 - $2.09 $70,119 - $116,308	55,650 Added 2.92%	1,963,432 $2.77 Million
Q2 2022 Aug 12, 2022	BUY	$0.97 - $3.08 $46,608 - $147,994	48,050 Added 2.58%	1,907,782 $2.29 Million
Q1 2022 May 13, 2022	SELL	$2.55 - $5.23 $187,453 - $384,462	-73,511 Reduced 3.8%	1,859,732 $5.39 Million
Q4 2021 Feb 14, 2022	SELL	$4.43 - $8.33 $701,929 - $1.32 Million	-158,449 Reduced 7.58%	1,933,243 $8.56 Million
Q3 2021 Nov 12, 2021	BUY	$6.07 - $9.89 $3.33 Million - $5.42 Million	547,899 Added 35.49%	2,091,692 $15.2 Million
Q2 2021 Aug 13, 2021	BUY	$9.76 - $14.15 $15.1 Million - $21.8 Million	1,543,793 New	1,543,793 $15.1 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.